All eyes are on the May CPI inflation index reading due out this Friday.
China's lockdowns appear to be ending and the chip shortage for automobiles appears to be easing and ahead of even the most optimistic hopes of a second half 2022 return to normalcy.
• Earnings risk in the next cycle, starting in mid to late July could be the driver of the next down leg in the market according to Morgan Stanley.
• Several auto makers are saying the chip crisis is easing well ahead of the second half of the year hope.
• China is opening up after COVID lockdowns.
Headlines of the Day
Morgan Stanley Sees Earnings Risks Weighing on Stocks
Companies slow to guide down in the absence of recession. Strategist says bear market may end in next earnings season.
Carmakers Feel Chip Crisis Easing as Global Growth Slows
Mercedes, Daimler Truck, BMW, VW say plants running as normal. Tentative improvement comes months ahead of predictions.
Beijing, Shanghai Reopening Speed Up
Infections are trending down nationwide, thanks to the ebbing outbreaks in Shanghai and Beijing. Of China’s top 50 cities by economic size, none currently have widespread restrictions in place.
Why Peak Inflation Is Near, According to Experts Who Bet on Short-Lived Price Rises
With inflation now exceeding 8% in the euro area, and expected to stay above that level in the US when May data comes out on Friday, here’s a roundup of some of the main arguments laid out by Team Transitory 2.0.
US Recession Odds Within the Next Year Now 30%, Survey Shows
The probability of a recession over the next 12 months is now 30%, the highest since 2020, according to the latest Bloomberg monthly survey of economists.
Economic Data Due Tomorrow on 6-7-2022
Consumer Credit Change APR
LMI Logistics Managers Index
The information contained on this site is provided for general informational purposes, as a convenience to the readers. The materials are not a substitute for obtaining professional advice from a qualified person, firm or corporation. Consult the appropriate professional advisor for more complete and current information. Capital Market Laboratories (“The Company”) does not engage in rendering any legal or professional services by placing these general informational materials on this website.
The Company specifically disclaims any liability, whether based in contract, tort, strict liability or otherwise, for any direct, indirect, incidental, consequential, or special damages arising out of or in any way connected with access to or use of the site, even if we have been advised of the possibility of such damages, including liability in connection with mistakes or omissions in, or delays in transmission of, information to or from the user, interruptions in telecommunications connections to the site or viruses.
The Company makes no representations or warranties about the accuracy or completeness of the information contained on this website. Any links provided to other server sites are offered as a matter of convenience and in no way are meant to imply that The Company endorses, sponsors, promotes or is affiliated with the owners of or participants in those sites, or endorse any information contained on those sites, unless expressly stated."